methyldopa has been researched along with Parkinsonian Disorders in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
GRODEN, BM | 1 |
CLARK, WG; MARKHAM, CH; WINTERS, WD | 1 |
MARSH, DO; MARSHALL, J; SCHNIEDEN, H | 1 |
PEASTON, MJ | 1 |
PRESCOTT, LF | 1 |
MENON, GN | 1 |
BROWN, WT; MURPHY, GF; PIVNICKI, D; SAINTCYR, S; SANKOFF, I; SOURKES, TL; WISEMAN-DISTLER, H | 1 |
7 other study(ies) available for methyldopa and Parkinsonian Disorders
Article | Year |
---|---|
Parkinsonism occurring with methyldopa treatment.
Topics: Antihypertensive Agents; Humans; Methyldopa; Parkinson Disease; Parkinsonian Disorders | 1963 |
EFFECT OF ALPHA-METHYL DOPA AND RESERPINE IN HUNTINGTON'S CHOREA, PARKINSON'S DISEASE AND OTHER MOVEMENT DISORDERS.
Topics: Adolescent; Chorea; Dystonia Musculorum Deformans; Dystonic Disorders; Genetic Diseases, X-Linked; Humans; Huntington Disease; Methyldopa; Movement Disorders; Parkinson Disease; Parkinsonian Disorders; Reserpine; Selective Serotonin Reuptake Inhibitors; Serotonin; Torticollis; Tremor | 1963 |
A CONTROLLED CLINICAL TRIAL OF ALPHA METHYL DOPA IN PARKINSONIAN TREMOR.
Topics: Depression; Depressive Disorder; Hypnotics and Sedatives; Methyldopa; Parasympatholytics; Parkinsonian Disorders; Phenobarbital; Placebos; Toxicology; Tremor | 1963 |
PARKINSONISM ASSOCIATED WITH ALPHA-METHYLDOPA THERAPY.
Topics: Antihypertensive Agents; Brain Diseases; Humans; Methyldopa; Parkinsonian Disorders; Pempidine; Pentolinium Tartrate; Selective Serotonin Reuptake Inhibitors; Serotonin | 1964 |
METHYLDOPA AND PARKINSONISM.
Topics: Antihypertensive Agents; Drug Therapy; Hypertension; Methyldopa; Parkinsonian Disorders; Toxicology | 1964 |
PARKINSONISM--AN UNUSUAL COMPLICATION OF ALPHA METHYL DOPA THERAPY.
Topics: Drug Therapy; Geriatrics; Methyldopa; Parkinsonian Disorders; Toxicology | 1965 |
A CLINICAL AND METABOLIC STUDY OF DOPA (3, 4-DIHYDROXYPHENYLALANINE) AND METHYLDOPA IN HUNTINGTON'S CHOREA.
Topics: Body Fluids; Chorea; Dihydroxyphenylalanine; Drug Therapy; Electroencephalography; Fluids and Secretions; Humans; Huntington Disease; Injections; Injections, Intravenous; Leriche Syndrome; Metabolism; Methyldopa; Parkinsonian Disorders; Urine | 1965 |